Therapeutic combinations to treat red blood cell disorders

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12150975
APP PUB NO 20190167767A1
SERIAL NO

16320647

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is related to a combination useful in the prevention and/or treatment of red blood cell disorders, in particular, acute and chronic complications associated with red blood cell dysfunction, increased red blood cell cholesterol and decreased plasma levels of lipophilic antioxidant (sickle cell disease, thalassemia, diabetes). The invention in particular relates to pharmaceutical formulations, regimens, methods of treatment and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HARTIS-PHARMA SARLCHEMIN DE BONMONT 13 C NYON CH-1260

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benghozi, Renee Charenton le Pont, FR 1 0
Lamour, Francois Blotzheim, FR 2 1
Niesor, Joseph Eric Nyon, CH 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 26, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 May 26, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 26, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00